ACADIA Pharmaceuticals Inc. - Common Stock — Liquidità (NASDAQ:ACAD) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -136.17 M-125.66 M-114.03 M16.7 M157.72 M109.84 M 123.49 M Flussi di cassa derivanti dalle attività di investimento 192.51 M-71.1 M73.24 M32 M-30.54 M-302.56 M -112.23 M Liquidità derivante dalle attività di finanziamento 81 M18.16 M8.2 M25.13 M6.84 M49.88 M 52.28 M Liquidità libera -136.17 M-125.66 M-114.03 M16.7 M157.72 M6.31 M 113.89 M

ACADIA Pharmaceuticals Inc. - Common Stock

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.

Notizie

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh

MYGN Cancer Care Strategy: What's Driving 2026 Growth Plans

ACADIA Pharmaceuticals Inc. (ACAD) Presents at Bank of America Global Healthcare Conference 2026 Transcript

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Canaccord conferma il rating su Acadia Pharmaceuticals dopo i risultati Q1

ACADIA Pharmaceuticals: le vendite dei farmaci possono mantenere lo slancio?

ACADIA Q1 2026: ricavi in crescita dell’11% nonostante utili sotto attese

Acadia Pharmaceuticals (ACAD) Lags Q1 Earnings and Revenue Estimates

ImmunityBio to Report Q1 Earnings: What's in the Cards?

IQVIA Set to Report Q1 Earnings: Here's What You Should Know

Guardian Pharmacy Services to Report Q1 Earnings: What's in the Cards?

CSLLY vs. ACAD: Which Stock Is the Better Value Option?